Select Page
Responsive Centered YouTube Video
Analysis of rising liver disease cases and reluctance to address underlying issues.
  • Focus on autoimmunity in severe COVID-19 cases triggering immune system to attack itself. 0:11

  • Upcoming webinar on potential mechanisms of rising liver disease, with free and donation-based tickets available. 1:04

  • Importance of addressing ‘elephant in the room’ to properly manage crises and challenges. 1:34

  • Observation of reluctance by politicians and industry to address critical issues affecting society. 2:05

  • Reference to data analysis on excess mortality causes in England by outside Allen. 2:23

Alarming increase in liver disease mortality rates analyzed by condition and timeline.
  • Breakdown of excess mortality by condition and percentage above normal 3:11

  • Color-coded representation of mortality rates based on percentage deviation 3:33

  • Analysis of data from March 2020 to December 2023 4:07

  • Identification of key conditions contributing to high mortality rates 4:40

  • Notable increase in mortality due to heart failure and ischemic heart disease 5:03

  • Unexpected rise in mortality related to cirrhosis highlighted in the data 5:20

Elevated liver disease rates observed from late 2022 to 2023, with a focus on understanding disease mechanisms and impacts on patients.
  • Liver disease rates remained high, exceeding 20% above baseline in June 2023. 6:14

  • Liver diseases such as hepatitis, cirrhosis, and liver cancer are significant health concerns. 7:31

  • Autoimmune liver diseases and their potential connection to SARS-CoV-2 are being researched. 9:01

Autoimmunity in liver disease possibly linked to SARS-CoV-2 infection and vaccination.
  • Autoimmunity can be triggered by severe acute respiratory syndrome coronavirus 2. 9:19

  • Patients with autoimmune liver disease may not have increased risk of SARS-CoV-2 infection. 10:16

  • SARS-CoV-2 infection may lead to the development of autoimmune diseases, including autoimmune hepatitis. 10:30

  • Reports suggest a possible association between SARS-CoV-2 vaccines and autoimmune hepatitis. 11:24

  • Liver disease with autoimmunity can go undetected until significant damage is present. 12:02

  • Combining infection and vaccination may lead to a heightened immune response. 12:17

Risk of autoimmune responses in liver disease due to immune priming and infection.
  • Liver under stress may have reduced threshold for damage. 12:54

  • Advice on alcohol consumption and liver health. 13:24

  • Combining infection and liver stress increases risk of disease. 13:41

  • Importance of not underestimating the effects of combined factors. 13:52

  • Circulating virus can trigger autoimmunity and damage. 14:14

  • Research needed to understand impact and mitigation strategies. 14:20

  • Join event on February 29 for more information. 14:31